| CAPE CORAL, Fla., Nov. 2, 2011 /PRNewswire/ -- Nature's Bioceuticals, a wholly owned subsidiary of Mistral Ventures Inc. (MILV.pk - News) announced that it has reached an agreement in principal with the inventor of a formula that could have life changing results for hundreds of millions of people worldwide afflicted with the disease. It is expected that the formal agreement will be executed in the coming week, at which point details of the product will be released. Robert deZanger, CEO of Natures Bio...continued MILV |
Wednesday, November 2, 2011
Nature's Bioceuticals Close to Finalizing Strategic Transaction in One of the Largest Drug Markets
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment